{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:47:58Z","timestamp":1771912078662,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008046","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T16:12:49Z","timestamp":1504714369000},"page":"e8046","source":"Crossref","is-referenced-by-count":42,"title":["Tenofovir alafenamide nephrotoxicity in an HIV-positive patient"],"prefix":"10.1097","volume":"96","author":[{"given":"Tessa K.","family":"Novick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaithin A.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-55-20210226","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.semnephrol.2008.08.009","article-title":"Antiretroviral nephrotoxicities","volume":"28","author":"Atta","year":"2008","journal-title":"Semin Nephrol"},{"key":"R2-55-20210226","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3851\/IMP2770","article-title":"Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity","volume":"19","author":"Bam","year":"2014","journal-title":"Antivir Ther"},{"key":"R3-55-20210226","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.2008.252","article-title":"Rosiglitazone reverses tenofovir-induced nephrotoxicity","volume":"74","author":"Lib\u00f3rio","year":"2008","journal-title":"Kidney Int"},{"key":"R4-55-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/apc.2007.0052","article-title":"Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system","volume":"22","author":"Gupta","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R5-55-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R6-55-20210226","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"R7-55-20210226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3181a666eb","article-title":"Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats","volume":"51","author":"Lebrecht","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-55-20210226","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"R9-55-20210226","doi-asserted-by":"crossref","first-page":"e5146","DOI":"10.1097\/MD.0000000000005146","article-title":"The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: meta-analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R10-55-20210226","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/QAI.0000000000000908","article-title":"Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single-arm, multicenter, open-label phase 3 study","volume":"71","author":"Pozniak","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-55-20210226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14740331003627458","article-title":"Renal toxicity associated with tenofovir use","volume":"9","author":"Rodriguez-N\u00f3voa","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R13-55-20210226","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1681\/ASN.2008030336","article-title":"Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction","volume":"19","author":"Sun","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R14-55-20210226","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ckj\/sfv041","article-title":"Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series","volume":"8","author":"Waheed","year":"2015","journal-title":"Clin Kidney J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:08Z","timestamp":1620959588000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709080-00055"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":13,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008046","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}